Introduction to Bio-Based Adipic Acid

Synthetic biology has emerged as a transformative force in industrial chemistry. Historically, adipic acid production has relied heavily on petrochemical processes. This specific diacid serves as a critical monomer for nylon, which is indispensable for producing high-quality surgical sutures and medical devices. However, traditional synthesis methods often involve hazardous chemicals and high energy consumption. Consequently, researchers have sought biological alternatives that align with green chemistry principles. A groundbreaking study led by Klass et al. introduces a novel pathway for adipic acid production using engineered polyketide synthases (PKSs). By reprogramming these modular enzymes, the team successfully synthesized adipic acid in microbial hosts. This development represents a significant milestone in metabolic engineering. It offers a blueprint for creating non-native compounds through highly chimeric systems. For healthcare professionals and pharmaceutical scientists in India, this progress signals a shift toward more sustainable manufacturing. Local production of medical precursors could reduce dependency on global supply chains. Furthermore, the ability to fine-tune enzyme pathways allows for the creation of specialized diacids with unique properties. Ultimately, these biological platforms could revolutionize how we source essential materials for clinical and industrial applications.

Modularity of Polyketide Synthases

Polyketide synthases are nature's assembly lines, consisting of multiple modules that catalyze the sequential addition of chemical building blocks. Each module typically includes an acyltransferase, a ketosynthase, and an acyl carrier protein. Specifically, these enzymes are known for producing complex natural products like antibiotics and immunosuppressants. However, canonical PKSs rarely produce dicarboxylic acids like adipic acid. This limitation exists because most loading modules do not retain the terminal carboxyl group during the extension process. To overcome this hurdle, the research team employed a retrobiosynthetic approach. They looked for unique enzymatic parts that could handle specific substrates like succinyl-CoA. This method allowed them to identify the necessary components for a non-canonical pathway. By understanding the modular nature of PKSs, the scientists could rearrange domains to form new functional units. This structural modularity makes PKSs ideal candidates for producing a wide variety of specialty chemicals. Consequently, engineering these systems requires a deep understanding of protein-protein interactions and metabolic flux. Such innovation is particularly relevant for India’s growing biotechnology sector, where efficient biocatalysts are in high demand for drug discovery and manufacturing processes.

Innovative EtnB Modules in Adipic Acid Production

The identification of the EtnB module proved pivotal for the success of this research. Unlike standard PKS loading modules, EtnB is a succinyl-CoA-loading module that uniquely retains its terminal carboxyl group. This specific characteristic enables the direct synthesis of dicarboxylic polyketide products. During the study, the researchers coupled EtnB to a fully reducing extension module. They utilized an engineered communication linker to optimize interactions between the acyl carrier protein and the ketosynthase. This modification significantly enhanced the selective loading of succinyl-CoA, which is the primary precursor for adipic acid production. Furthermore, the integration of these domains required precise engineering of the protein junctions to maintain enzymatic activity. By demonstrating successful carboxyl retention, the team has expanded the PKS toolkit for future metabolic engineering projects. This breakthrough allows for the production of various diacids that were previously difficult to access through biological means. Consequently, this platform can be adapted to produce other high-value chemicals for the pharmaceutical industry. For instance, modified diacids can serve as building blocks for biodegradable polymers used in drug delivery. Therefore, the EtnB module serves as a cornerstone for sustainable and versatile chemical synthesis.

Engineering Chimeric PKS Across Species

The study describes one of the most extensively hybridized PKS systems engineered to date. This complex construct integrates genetic material from five different organisms. Specifically, it involves domains from seven distinct PKS modules joined across six non-natural junctions. Engineering such a chimeric system is a monumental challenge due to the risk of functional failure at the junctions. To ensure functionality, the researchers focused on rational design and optimization of communication linkers. These linkers facilitate the smooth transfer of intermediates between modules, preventing the stalling of the assembly line. Moreover, the team tested this functional construct in both Escherichia coli and Pseudomonas putida. Both hosts demonstrated the ability to harbor the complex pathway and produce adipic acid. However, P. putida showed particular promise due to its robust metabolic profile and tolerance for industrial conditions. This versatility suggests that chimeric PKSs can be rendered functional through careful engineering of protein interfaces. Additionally, the success of this project highlights the potential of using synthetic biology to create enzymes that do not exist in nature. Such advancements are crucial for the development of new biocatalysts that can operate efficiently under varying industrial parameters.

Metabolic Rewiring for Industrial Tiers

Beyond enzyme engineering, the researchers performed extensive host strain metabolic rewiring to maximize yields. This involved optimizing the supply of extender units like malonyl-CoA within the cell. Furthermore, the team performed AT domain exchanges to improve the substrate specificity of the PKS system. These changes ensured that the microbes prioritized the production of adipic acid over competing metabolic pathways. Consequently, the titers of the desired product increased significantly. In India, where pharmaceutical companies are increasingly adopting green manufacturing practices, such host-strain optimization is vital. By leveraging the natural metabolic capabilities of organisms like E. coli, manufacturers can produce high-purity chemical intermediates with lower environmental impact. Additionally, the study explored the impact of different growth conditions on enzyme performance. This holistic approach, combining enzyme design with strain engineering, provides a comprehensive framework for industrial scale-up. Consequently, the researchers have established a versatile platform for engineering not just diacids, but a range of non-canonical products. This approach paves the way for a bio-based economy where microbes serve as the primary producers of essential industrial monomers.

Future Clinical and Pharmaceutical Outlook

The successful engineering of a hybrid PKS for adipic acid production marks a turning point in synthetic biology. By integrating parts from multiple organisms, scientists have proven that modular enzymes can be repurposed for non-native chemical synthesis. This achievement is particularly relevant for the medical device industry, which relies on adipic acid derivatives for polymer production. Medical-grade nylon is essential for sutures and catheters used in surgical procedures across India. By developing biological routes for these materials, we ensure a sustainable supply. Moreover, the techniques used in this study, such as linker engineering and domain exchange, can be applied to produce novel antibiotics and anticancer agents. Therefore, the impact of this work extends far beyond industrial chemistry into therapeutic development. As synthetic biology evolves, the ability to design custom microbes will become a standard tool in pharmaceutical science. This research provides the foundation for a new era of biomanufacturing that is both efficient and environmentally responsible. Ultimately, the integration of these technologies will drive innovation in how we manufacture the building blocks of modern medicine.

FAQs

How does the EtnB module differentiate itself from canonical PKS loading modules?

The EtnB module serves as a specialized succinyl-CoA-loading module that uniquely retains its terminal carboxyl group during the polyketide extension process. In contrast, canonical PKS loading modules typically do not preserve this carboxyl moiety, which limits their ability to produce dicarboxylic acids. By maintaining this structure, EtnB enables researchers to access a wider range of dicarboxylic polyketide products. This unique capability is essential for the sustainable synthesis of industrial monomers like adipic acid.

What are the primary advantages of producing adipic acid via PKS-based pathways?

Utilizing engineered PKS pathways for adipic acid production offers a significant advantage over traditional petrochemical methods by providing a more sustainable alternative. Biological synthesis reduces the reliance on hazardous chemicals like benzene and lowers energy requirements. Additionally, the modular nature of PKS enzymes allows for high precision in product design. This precision ensures high-purity outputs, which are vital for medical applications such as the production of surgical sutures and biodegradable drug delivery systems.

How does host strain metabolic rewiring improve the titers of adipic acid?

Metabolic rewiring involves the deliberate modification of the host organism's internal chemistry to maximize the availability of necessary precursors. Specifically, researchers optimize the intracellular supply of extender units like malonyl-CoA to support the PKS pathway. Furthermore, by deleting competing metabolic routes and performing AT domain exchanges, the researchers ensure that the cell's resources are primarily directed toward the target compound. Consequently, these modifications significantly enhance the final concentration of adipic acid in the microbial culture.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional endorsement. Readers should consult with a qualified healthcare professional or a pharmaceutical expert before making decisions related to industrial production or clinical applications. Refer to the latest local and national guidelines for clinical practice.

References

Klass SH et al. Engineering an Extremely Hybrid PKS for Adipic Acid Production. ACS Synth Biol. 2026 Jun 24. doi: 10.1021/acssynbio.5c00972. PMID: 42339614.

Willett H. Bioproduction of Adipic Acid Using Engineered Pseudomonas Putida. UNL Digital Commons. 2026.

Rice AJ, et al. Cell-free synthetic biology for natural product biosynthesis and discovery. Chemical Society Reviews. 2025;54:4314-4352.